ArticleFrontiers in oncology2026
Case report of a giant hypervascular mediastinal mass with airway and SVC compromise managed without preoperative biopsy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale: To summarize the clinical experience of multidisciplinary management for giant hypervascular mediastinal follicular dendritic cell sarcoma. Patient concerns: A 37-year-old man had a one-week history of progressive dyspnea, orthopnea, and morning facial swelling. Diagnoses: Preoperative imaging suggested Castleman disease as the leading differential diagnosis, and pathological examination confirmed follicular dendritic cell sarcoma (FDCS). Interventions: The patient received an effective strategy under the supervision of multidisciplinary specialists, including 3D reconstruction for precise surgical planning, preoperative angioembolization to reduce vascularity, awake fiberoptic intubation, and video-assisted thoracoscopic surgery (VATS). Learning points: In hypervascular mediastinal tumors, angioembolization of feeding vessels performed on the day of surgery maximally reduces intraoperative bleeding while avoiding complications of prolonged devascularization. When tracheal stenosis and SVC syndrome coexist, a sequential positioning strategy is essential: tumor-side tilt for awake intubation, followed by left lateral decubitus to relieve SVC compression. When biopsy risk is prohibitive, upfront surgical resection offers simultaneous decompression and definitive diagnosis after multidisciplinary discussion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.